The emerging therapy of the medication represents a significant advance in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide502992.bloggerchest.com/42151562/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment